Ruthenium-106 (

To describe the clinical and imaging features of circumscribed choroidal hemangiomas (CCH) and their treatment outcomes with Ruthenium-106 ( Retrospective study of 24 patients (24 eyes) diagnosed with CCH and treated with The mean age at presentation was 36 years (range, 16-57). The most common tumor location was the temporal quadrant ( Ruthenium-106 plaque brachytherapy is effective for CCH (> 3 mm height) as a primary and salvage treatment for tumors unresponsive to other modalities.

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.